Full Name
Han Kiat Ho
Variants
Ho, H.K.
Ho H.K
Ho, Han Kiat
Ho Han Kiat
 
Main Affiliation
 
 
Email
phahohk@nus.edu.sg
 
 

Publications

Results 1-20 of 53 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
12020A study protocol for HEalth-Related quality of life-intervention in survivors of Breast and other cancers experiencing cancer-related fatigue using TraditionAL Chinese Medicine: the HERBAL trialYap, N.Y.; Loo, W.S.; Zheng, H.F.; Tan, Q.M.; Tan, T.K.; Quek, L.Y.P.; Tan, C.J.; Toh, Y.L.; Ng, C.C. ; Ang, S.K.; Tan, V.K.M.; Ho, H.K. ; Chew, L. ; Loh, K.W.-J.; Tan, T.J.Y.; Chan, A.
22019An Evaluation of DNA Methyltransferase 1 (DNMT1) Single Nucleotide Polymorphisms and Chemotherapy-Associated Cognitive Impairment: A Prospective, Longitudinal StudyChan, A. ; Yeo, A. ; Shwe, M. ; Tan, C.J.; Foo, K.M.; Chu, P.; Khor, C.C.; Ho, H.K. 
32020An evaluation of the in vitro roles and mechanisms of silibinin in reducing pyrazinamide-and isoniazid-induced hepatocellular damageGoh, Z.-H.; Tee, J.K. ; Ho, H.K. 
4Aug-2012An investigation of the bioactivation potential and metabolism profile of zebrafish versus humanChng, H.T.; Ho, H.K. ; Yap, C.W. ; Lam, S.H. ; Chan, E.C.Y. 
519-Feb-2019Angiopoietin-1 accelerates restoration of endothelial cell barrier integrity from nanoparticle-induced leakinessJie Kai Tee ; Magdiel Setyawati ; Fei Peng ; David Leong ; Han Kiat Ho 
61-Feb-2014Asian study of clopidogrel (ASCLOP) responsiveness: The contributions of genetic and non-genetic factorsTan, D.S.Y. ; Yeo, A.H.L.; Ho, H.K. ; Wee, H.L. ; Ong, H.Y.
72019Association of plasma leptin, pro-inflammatory adipokines and cancer-related fatigue in early-stage breast cancer patients: A prospective cohort studyToh, Y.L.; Tan, C.J.; Yeo, A.H.L. ; Shwe, M. ; Ho, H.K. ; Gan, Y.X.; Foo, K.M.; Chu, P.; Olson, K.; Chan, A. 
8Oct-2006Bioactivation and hepatotoxicity of nitroaromatic drugsBoelsterli, U.A. ; Ho, H.K. ; Zhou, S. ; Leow, K.Y.
9Dec-2013Carbon nanotubes for delivery of small molecule drugsWong, B.S.; Yoong, S.L.; Jagusiak, A.; Panczyk, T.; Ho, H.K. ; Ang, W.H. ; Pastorin, G. 
101-Nov-2021Cerium Oxide Nanoparticles Alleviate Hepatic Fibrosis Phenotypes In VitroBoey, Adrian ; Leong, Shu Qing; Bhave, Sayali ; Ho, Han Kiat 
112015Comparative hepatoprotective effects of tocotrienol analogs against drug-induced liver injuryTan, Cheauyih; Saw, Tzuenyih; Fong, Cheewai; Ho, Han Kiat 
12Jan-2014Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerationsHo, H.K. ; Yeo, A.H.L.; Kang, T.S. ; Chua, B.T.
135-Dec-2013Cytokines as mediators of chemotherapy-associated cognitive changes: Current evidence, limitations and directions for future researchCheung, Y.T.; Lim, S.R.; Ho, H.K. ; Chan, A. 
14Apr-2013Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testingHo, H.K. ; Németh, G.; Ng, Y.R.; Pang, E.; Szántai-Kis, C.; Zsákai, L.; Breza, N.; Greff, Z.; Horváth, Z.; Pató, J.; Szabadkai, I.; Szokol, B.; Baska, F.; Orfi, L.; Ullrich, A.; Kéri, G.; Chua, B.T.
15Jun-2010Direct toxicity effects of sulfo-conjugated troglitazone on human hepatocytesSaha, S.; New, L.S. ; Ho, H.K. ; Chui, W.K. ; Chan, E.C.Y. 
56Jun-2012Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: Clinical and in vitro evidenceTeo, Y.L.; Saetaew, M.; Chanthawong, S.; Yap, Y.S.; Yong Chan, E.C. ; Ho, H.K. ; Chan, A. 
57Jan-2014Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatinYoong, S.L.; Wong, B.S.; Zhou, Q.L.; Chin, C.F.; Li, J. ; Venkatesan, T. ; Ho, H.K. ; Yu, V.; Ang, W.H. ; Pastorin, G. 
581-Aug-2022Evaluation of anthoxanthins and their actions on digestive enzyme inhibition when used independently and in combinationKoh, YQ ; Sin, YAD; Rong, HJ; Chua, THS; Ho, SHS; Ho, HK 
592017Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: A longitudinal studyNg T.; Lee Y.Y.; Chae J.-W.; Yeo A.H.L. ; Shwe M. ; Gan Y.X.; Ng R.C.H. ; Chu P.P.Y.; Khor C.C. ; Ho H.K. ; Chan A. 
601-Dec-2021Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver DiseaseBhave, Sayali ; Ho, Han Kiat